JPS635025B2 - - Google Patents

Info

Publication number
JPS635025B2
JPS635025B2 JP57172936A JP17293682A JPS635025B2 JP S635025 B2 JPS635025 B2 JP S635025B2 JP 57172936 A JP57172936 A JP 57172936A JP 17293682 A JP17293682 A JP 17293682A JP S635025 B2 JPS635025 B2 JP S635025B2
Authority
JP
Japan
Prior art keywords
sup
lower alkyl
hydrogen
alkyl group
pyridyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP57172936A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5980664A (ja
Inventor
Ikuo Ueda
Masanobu Nagano
Atsushi Akaha
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Priority to JP57172936A priority Critical patent/JPS5980664A/ja
Priority to GR72407A priority patent/GR78525B/el
Priority to DK421183A priority patent/DK157854C/da
Priority to KR1019830004386A priority patent/KR900004694B1/ko
Priority to FI833369A priority patent/FI80878C/fi
Priority to ZA837069A priority patent/ZA837069B/xx
Priority to US06/535,298 priority patent/US4564621A/en
Priority to EP83109659A priority patent/EP0105458B1/en
Priority to ES526026A priority patent/ES8603421A1/es
Priority to DE8383109659T priority patent/DE3380876D1/de
Priority to AT83109659T priority patent/ATE48130T1/de
Priority to MX839783A priority patent/MX154922A/es
Priority to NO833529A priority patent/NO162017C/no
Priority to CA000437939A priority patent/CA1246573A/en
Priority to HU833400A priority patent/HU193046B/hu
Publication of JPS5980664A publication Critical patent/JPS5980664A/ja
Publication of JPS635025B2 publication Critical patent/JPS635025B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/57—Nitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/56—Amides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
JP57172936A 1982-09-30 1982-09-30 α−アリ−ル−α−ピリジル脂肪酸誘導体およびその製法 Granted JPS5980664A (ja)

Priority Applications (15)

Application Number Priority Date Filing Date Title
JP57172936A JPS5980664A (ja) 1982-09-30 1982-09-30 α−アリ−ル−α−ピリジル脂肪酸誘導体およびその製法
GR72407A GR78525B (en]) 1982-09-30 1983-09-08
DK421183A DK157854C (da) 1982-09-30 1983-09-15 Analogifremgangsmaade til fremstilling af alfa-aryl-alfa-(2-pyridyl)-alkansyrederivater
KR1019830004386A KR900004694B1 (ko) 1982-09-30 1983-09-19 신규 α-아릴-α-피리딜 알카노인산 유도체의 제조방법
FI833369A FI80878C (fi) 1982-09-30 1983-09-21 Foerfarande foer framstaellning av farmakologiskt anvaendbara -aryl- -pyridylalkansyraderivat.
ZA837069A ZA837069B (en) 1982-09-30 1983-09-22 Alpha-aryl-alpha-pyridylalkanoic acid derivatives,process for preparation thereof and pharmaceutical composition comprising the same
US06/535,298 US4564621A (en) 1982-09-30 1983-09-23 α-Aryl-α-pyridylalkanoic acid derivatives, process for preparation thereof and pharmaceutical composition comprising the same
EP83109659A EP0105458B1 (en) 1982-09-30 1983-09-28 Alpha-aryl-alpha-pyridylalkanoic acid derivatives, process for preparation thereof and pharmaceutical composition comprising the same
ES526026A ES8603421A1 (es) 1982-09-30 1983-09-28 Un procedimiento para preparar nuevos derivados de acido -aril- -piridilalcanoico
DE8383109659T DE3380876D1 (en) 1982-09-30 1983-09-28 Alpha-aryl-alpha-pyridylalkanoic acid derivatives, process for preparation thereof and pharmaceutical composition comprising the same
AT83109659T ATE48130T1 (de) 1982-09-30 1983-09-28 Alpha-aryl-alpha-pyridylalkanoicsaeure-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzung.
MX839783A MX154922A (es) 1982-09-30 1983-09-28 Procedimiento para preparar derivados de acidos grasos de alfa-aril-alfa piridilo
NO833529A NO162017C (no) 1982-09-30 1983-09-29 Analogifremgangsmaate for fremstilling av terapeutisk aktive alfa-aryl-alfa-pyridylalkansyrederivater.
CA000437939A CA1246573A (en) 1982-09-30 1983-09-29 .alpha.-ARYL-.alpha.-PYRIDYLALKANOIC ACID DERIVATIVES, PROCESS FOR PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
HU833400A HU193046B (en) 1982-09-30 1983-09-29 Process for preparing aplha-aryl-alpha-pyridyl-alkyl-carboxylic acid derivatives and pharmaceutical compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57172936A JPS5980664A (ja) 1982-09-30 1982-09-30 α−アリ−ル−α−ピリジル脂肪酸誘導体およびその製法

Publications (2)

Publication Number Publication Date
JPS5980664A JPS5980664A (ja) 1984-05-10
JPS635025B2 true JPS635025B2 (en]) 1988-02-01

Family

ID=15951089

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57172936A Granted JPS5980664A (ja) 1982-09-30 1982-09-30 α−アリ−ル−α−ピリジル脂肪酸誘導体およびその製法

Country Status (14)

Country Link
US (1) US4564621A (en])
EP (1) EP0105458B1 (en])
JP (1) JPS5980664A (en])
KR (1) KR900004694B1 (en])
AT (1) ATE48130T1 (en])
CA (1) CA1246573A (en])
DE (1) DE3380876D1 (en])
DK (1) DK157854C (en])
ES (1) ES8603421A1 (en])
FI (1) FI80878C (en])
GR (1) GR78525B (en])
HU (1) HU193046B (en])
NO (1) NO162017C (en])
ZA (1) ZA837069B (en])

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60112762A (ja) * 1983-11-21 1985-06-19 Fujisawa Pharmaceut Co Ltd α−アリ−ル−α−ピリジル脂肪酸誘導体およびその製法
US4810703A (en) * 1984-10-19 1989-03-07 A. H. Robins Company, Incorporated 1-((aminoalkyl and aminoalkylamino)carbonyl and thiocarbonyl)-alpha, alpha-diarylpyrrolidine, piperidine and homopiperidineacetamides and acetonitriles
US4783537A (en) * 1985-11-13 1988-11-08 Pennwalt Corporation α-(aminoalkyl)-arylacetic acid derivatives
US5202331A (en) * 1990-04-18 1993-04-13 Fujisawa Pharmaceutical Co., Ltd. Therapeutic agent for dysuria comprising alpha-phenyl-alpha-pyridylalkanoic acid derivatives
JP5000841B2 (ja) * 2001-01-24 2012-08-15 カディラ ヘルスケア リミティド クロピドグレルの製造方法
US8748433B2 (en) 2010-04-30 2014-06-10 Merck Sharp & Dohme Corp. β3 adrenergic receptor agonists

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA501690A (en) * 1954-04-20 Schering Corporation Pyridyl substituted alkanes
NL70757C (en]) * 1947-10-13
FR1235903A (fr) * 1954-06-04 1960-11-10 Pharmacia Ab Procédé de préparation d'amides butyriles
US2991289A (en) * 1958-02-05 1961-07-04 Merck Ag E Derivatives of 1-aminopropane
GB915804A (en) * 1958-04-12 1963-01-16 Degussa Process for the production of basically substituted carboxylic acid amides
FR2485M (fr) * 1961-05-17 1964-04-27 Searle & Co Nouveaux régulateurs cardiaques.
US3225054A (en) * 1962-07-03 1965-12-21 Searle & Co 4-dipropylamino-2-aryl-2-pyridylalkanamides
JPS5248862B2 (en]) * 1971-08-16 1977-12-13

Also Published As

Publication number Publication date
FI80878B (fi) 1990-04-30
KR900004694B1 (ko) 1990-07-02
ES526026A0 (es) 1985-12-16
ATE48130T1 (de) 1989-12-15
FI80878C (fi) 1990-08-10
DK421183A (da) 1984-03-31
FI833369A7 (fi) 1984-03-31
EP0105458B1 (en) 1989-11-23
DE3380876D1 (en) 1989-12-28
ES8603421A1 (es) 1985-12-16
ZA837069B (en) 1984-05-30
KR840006238A (ko) 1984-11-22
HU193046B (en) 1987-08-28
DK421183D0 (da) 1983-09-15
EP0105458A2 (en) 1984-04-18
JPS5980664A (ja) 1984-05-10
NO162017B (no) 1989-07-17
EP0105458A3 (en) 1985-11-27
US4564621A (en) 1986-01-14
NO833529L (no) 1984-04-02
DK157854B (da) 1990-02-26
NO162017C (no) 1989-10-25
CA1246573A (en) 1988-12-13
FI833369A0 (fi) 1983-09-21
GR78525B (en]) 1984-09-27
DK157854C (da) 1990-07-23

Similar Documents

Publication Publication Date Title
US4238492A (en) Phenoxyalkylcarboxylic acids
US4560690A (en) 2-(N-substituted guanidino)-4-hetero-arylthiazole antiulcer agents
JPH0478628B2 (en])
SU1230467A3 (ru) Способ получени производных 1-циклогексил-4-арил-4-пиперидинкарбоновых кислот,или их кислотно-аддитивных солей,или их стереохимических изомерных форм (его варианты)
NO170883B (no) Fremgangsmaate for fremstilling av 2-amino-5-hydroksy-4-metylpyrimidin-derivater
DE2432410C2 (de) 2-[4-(Imidazo[1,2a][pyridin-2-yl)-phenyl]-propionsäuren, Verfahren zu ihrer Herstellung und ihre Verwendung
JPH0524917B2 (en])
JPS6253504B2 (en])
EP0249950B1 (en) Aromatic compounds
JPS623153B2 (en])
US6265409B1 (en) Pyridine derivatives and pharmaceutical compositions containing them
EP0007679A1 (en) Oxime ethers, processes for their manufacture and pharmaceutical compositions thereof
DE69132082T2 (de) Pyridin-Derivate, Verfahren zu deren Herstellung und Anwendung
JPS635025B2 (en])
JPS58206588A (ja) 抗潰瘍性２−グアニジノ−４−（２−置換−アミノ−４−イミダゾリル）チアゾ−ル類およびそれらの製造方法
US4526973A (en) Chemical compounds
EP0114572A1 (de) Substituierte Imidazo(1,5-a)pyridine
CS226020B2 (en) Method of preparing pyridine and pyrimidine derivatives
EP0068386A1 (de) Substituierte Imidazo(1,5-a)pyridine, Verfahren zu ihrer Herstellung und pharmazeutische Präparate die diese Verbindungen enthalten
DE60103752T2 (de) Verfahren zur herstellung von pyrazolopyridinderivaten
JPH0124145B2 (en])
DE3875030T2 (de) Leukotrien-antagonisten.
JPH07252260A (ja) 新規チエノチアジン誘導体、その製造方法及びその使用方法
EP0198633A2 (en) Pyridine derivatives
EP0115132B1 (en) Pyrimidone derivatives